Intracapsular and intravenous administration for TXA similar in efficacy and safety in TKA .
The Assessment of Blood Loss During Total Knee Arthroplasty When Comparing Intravenous vs Intracapsular Administration of Tranexamic Acid
J Arthroplasty. 2016 Nov;31(11):2452-2457131 patients scheduled for total knee arthroplasty were randomized to tranexamic acid administration via intracapsular injection at the end of the procedure or intravenous injections before and after the procedure. The purpose of this study was to compare blood loss, hemoglobin levels, transfusion rate, and thromboembolic complication rate between groups over the first 3 days postoperatively. Results demonstrated no significant differences between groups in any outcome measure.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
